|
1
|
Rabinovitch M, Guignabert C, Humbert M and
Nicolls MR: Inflammation and immunity in the pathogenesis of
pulmonary arterial hypertension. Circ Res. 115:165–175. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Tuder RM, Stacher E, Robinson J, Kumar R
and Graham BB: Pathology of pulmonary hypertension. Clin Chest Med.
34:639–650. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Zamanian RT, Kudelko KT, Sung YK, de Jesus
Perez V, Liu J and Spiekerkoetter E: Current clinical management of
pulmonary arterial hypertension. Circ Res. 115:131–147. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Nogueira-Ferreira R, Ferreira R and
Henriques-Coelho T: Cellular interplay in pulmonary arterial
hypertension: Implications for new therapies. Biochim Biophys Acta.
1843:885–893. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Perros F, Humbert M and Cohen-Kaminsky S:
Pulmonary arterial hypertension: A flavor of autoimmunity. Med Sci
(Paris). 29:607–616. 2013.(In French). View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Saei AA and Omidi Y: A glance at DNA
microarray technology and applications. Bioimpacts. 1:75–86.
2011.PubMed/NCBI
|
|
7
|
Szelinger S, Pearson JV and Craig DW:
Microarray-based genome-wide association studies using pooled DNA.
Methods Mol Biol. 700:49–60. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Menon S, Fessel J and West J: Microarray
studies in pulmonary arterial hypertension. Int J Clin Pract Suppl.
19–28. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Yu J, Wilson J, Taylor L and Polgar P: DNA
microarray and signal transduction analysis in pulmonary artery
smooth muscle cells from heritable and idiopathic pulmonary
arterial hypertension subjects. J Cell Biochem. 116:386–397. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Bull TM, Coldren CD, Moore M,
Sotto-Santiago SM, Pham DV, Nana-Sinkam SP, Voelkel NF and Geraci
MW: Gene microarray analysis of peripheral blood cells in pulmonary
arterial hypertension. Am J Respir Crit Care Med. 170:911–919.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Ha M and Kim VN: Regulation of microRNA
biogenesis. Nat Rev Mol Cell Biol. 15:509–524. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Hata A: Functions of MicroRNAs in
cardiovascular biology and disease. Annu Rev Physiol. 75:69–93.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
O'Connell RM, Rao DS and Baltimore D:
microRNA regulation of inflammatory responses. Annu Rev Immunol.
30:295–312. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Rhodes CJ, Wharton J, Boon RA, Roexe T,
Tsang H, Wojciak-Stothard B, Chakrabarti A, Howard LS, Gibbs JS,
Lawrie A, et al: Reduced microRNA-150 is associated with poor
survival in pulmonary arterial hypertension. Am J Respir Crit Care
Med. 187:294–302. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Wu D, Talbot CC Jr, Liu Q, Jing ZC, Damico
RL, Tuder R, Barnes KC, Hassoun PM and Gao L: Identifying microRNAs
targeting Wnt/β-catenin pathway in end-stage idiopathic pulmonary
arterial hypertension. J Mol Med (Berl). 94:875–885. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
National Research Council (US) Committee
on Educational Programs in Laboratory Animal Science, . Education
and Training in the Care and Use of Laboratory Animals: A Guide for
Developing Institutional Programs. National Academies Press;
Washington, DC: 1991
|
|
17
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(−Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Leotta M, Biamonte L, Raimondi L,
Ronchetti D, Di Martino MT, Botta C, Leone E, Pitari MR, Neri A,
Giordano A, et al: A p53-dependent tumor suppressor network is
induced by selective miR-125a-5p inhibition in multiple myeloma
cells. J Cell Physiol. 229:2106–2116. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Montani D, Günther S, Dorfmüller P, Perros
F, Girerd B, Garcia G, Jaïs X, Savale L, Artaud-Macari E, Price LC,
et al: Pulmonary arterial hypertension. Orphanet J Rare Dis.
8:972013. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Huertas A, Perros F, Tu L, Cohen-Kaminsky
S, Montani D, Dorfmüller P, Guignabert C and Humbert M: Immune
dysregulation and endothelial dysfunction in pulmonary arterial
hypertension: A complex interplay. Circulation. 129:1332–1340.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Wang Y, Xue XY, Liu YX, Wang KF, Zang XF,
Wang J, Wang PL, Zhang J, Pan L, Zhang SY and Wang JX: Pulmonary
arterial hypertension and microRNAs-an ever-growing partnership.
Arch Med Res. 44:483–487. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Courboulin A, Tremblay VL, Barrier M,
Meloche J, Jacob MH, Chapolard M, Bisserier M, Paulin R, Lambert C,
Provencher S and Bonnet S: Kruppel-like factor 5 contributes to
pulmonary artery smooth muscle proliferation and resistance to
apoptosis in human pulmonary arterial hypertension. Respir Res.
12:1282011. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Rde C Ferreira, Montenegro SM, Domingues
AL, Bandeira AP, Silveira CA, Leite LA, Cde A Pereira, Fernandes
IM, Mertens AB and Almeida MO: TGF beta and IL13 in Schistosomiasis
mansoni associated pulmonary arterial hypertension; a descriptive
study with comparative groups. BMC Infect Dis. 14:2822014.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Gore B, Izikki M, Mercier O, Dewachter L,
Fadel E, Humbert M, Dartevelle P, Simonneau G, Naeije R, Lebrin F
and Eddahibi S: Key role of the endothelial TGF-b/ALK1/endoglin
signaling pathway in humans and rodents pulmonary hypertension.
PLoS One. 9:e1003102014. View Article : Google Scholar : PubMed/NCBI
|
